Heller, Simon R <br/><br/>
Glycaemic outcomes of an Individualized treatMent aPproach for oldER vulnerable patIents: A randomized, controlled stUdy in type 2 diabetes Mellitus (IMPERIUM).  [electronic resource] 

 -  Diabetes, obesity & metabolism  01 2018 
 - 148-156 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1463-1326 
<br/><br/><label>Standard No.: </label>10.1111/dom.13051  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Aged<br/>Aged, 80 and over<br/>Aging<br/>Cohort Studies<br/>Diabetes Mellitus, Type 2--blood<br/>Drug Monitoring<br/>Drug Resistance<br/>Drug Therapy, Combination--adverse effects<br/>Feasibility Studies<br/>Female<br/>Frail Elderly<br/>Glucagon-Like Peptide-1 Receptor--metabolism<br/>Glycated Hemoglobin--analysis<br/>Humans<br/>Hyperglycemia--prevention & control<br/>Hypoglycemia--chemically induced<br/>Hypoglycemic Agents--administration & dosage<br/>Injections, Subcutaneous<br/>Male<br/>Patient Dropouts<br/>Pilot Projects<br/>Precision Medicine<br/>Severity of Illness Index<br/>Glucagon-Like Peptide-1 Receptor Agonists